Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The plasma Epstein-Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic area.
Liang H, Lv X, Wang L, Wu YS, Sun R, Ye YF, Ke LR, Yang Q, Yu YH, Qiu WZ, Liu GY, Huang XJ, Li WZ, Lv SH, Guo X, Xiang YQ, Xia WX. Liang H, et al. Among authors: yu yh. Ther Adv Med Oncol. 2018 Jul 20;10:1758835918782331. doi: 10.1177/1758835918782331. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 30046357 Free PMC article.
MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it.
Li WZ, Liu GY, Lin LF, Lv SH, Qiang MY, Lv X, Wu YS, Liang H, Ke LR, Wang DL, Yu YH, Qiu WZ, Liu KY, Guo X, Li JP, Zou YJ, Xiang YQ, Xia WX. Li WZ, et al. Among authors: yu yh. Radiother Oncol. 2020 Apr;145:101-108. doi: 10.1016/j.radonc.2019.12.018. Epub 2020 Jan 10. Radiother Oncol. 2020. PMID: 31931288
Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area.
Liang H, Xiang YQ, Lv X, Xie CQ, Cao SM, Wang L, Qian CN, Yang J, Ye YF, Gan F, Ke LR, Yu YH, Liu GY, Qiu WZ, Huang XJ, Wen CH, You N, Wang XQ, Guo X, Xia WX. Liang H, et al. Among authors: yu yh. Eur J Cancer. 2017 Mar;73:48-60. doi: 10.1016/j.ejca.2016.12.009. Epub 2017 Feb 3. Eur J Cancer. 2017. PMID: 28161498
Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
Ke LR, Xia WX, Qiu WZ, Huang XJ, Yang J, Yu YH, Liang H, Liu GY, Ye YF, Xiang YQ, Guo X, Lv X. Ke LR, et al. Among authors: yu yh. BMC Cancer. 2017 Feb 15;17(1):134. doi: 10.1186/s12885-017-3080-4. BMC Cancer. 2017. PMID: 28202000 Free PMC article. Clinical Trial.
Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.
Liu GY, Lv X, Wu YS, Mao MJ, Ye YF, Yu YH, Liang H, Yang J, Ke LR, Qiu WZ, Huang XJ, Li WZ, Guo X, Xiang YQ, Xia WX. Liu GY, et al. Among authors: yu yh. Cancer Commun (Lond). 2018 May 10;38(1):21. doi: 10.1186/s40880-018-0283-2. Cancer Commun (Lond). 2018. PMID: 29764487 Free PMC article.
1,132 results